Publicaciones (84) Publicaciones en las que ha participado algún/a investigador/a

2005

  1. A computer-based approach to the rational discovery of new trichomonacidal drugs by atom-type linear indices

    Current Drug Discovery Technologies, Vol. 2, Núm. 4, pp. 245-265

  2. A linear discrimination analysis based virtual screening of trichomonacidal lead-like compounds: Outcomes of in silico studies supported by experimental results

    Bioorganic and Medicinal Chemistry Letters, Vol. 15, Núm. 17, pp. 3838-3843

  3. A new pharmacological screening assay with Trypanosoma cruzi epimastigotes expressing β-galactosidase

    Parasitology Research, Vol. 95, Núm. 4, pp. 296-298

  4. A novel mutation of the α2-globin causing α+- thalassemia: Hb plasencia α125(H8)Leu→Arg (α2)

    Hemoglobin, Vol. 29, Núm. 2, pp. 113-117

  5. A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal compounds

    Bioorganic and Medicinal Chemistry, Vol. 13, Núm. 22, pp. 6264-6275

  6. A prospective, randomized, and comparative study of 3 different methods for the diagnosis of intravascular catheter colonization

    Clinical Infectious Diseases, Vol. 40, Núm. 8, pp. 1096-1100

  7. An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile

    Journal of Medical Microbiology

  8. Analysis of Mycobacterium tuberculosis genotypes in Madrid and identification of two new families specific to Spain-related settings

    Journal of Clinical Microbiology, Vol. 43, Núm. 4, pp. 1797-1806

  9. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.

    Biomédica : revista del Instituto Nacional de Salud, Vol. 25, Núm. 1, pp. 110-119

  10. Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: Analysis by site of isolation

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 8, pp. 3495-3497

  11. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients

    Clinical Microbiology and Infection, Vol. 11, Núm. 9, pp. 690-703

  12. Aportación de la caspofungina al tratamiento de la aspergilosis invasora

    Enfermedades Infecciosas y Microbiologia Clinica Monografias, Vol. 4, Núm. 3, pp. 3-9

  13. Aportación del laboratorio de microbiología al diagnóstico de la neumonía asociada a la ventilación mecánica

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. SUPPL.3, pp. 2-9

  14. Association between the infectivity of Mycobacterium tuberculosis strains and their efficiency for extrarespiratory infection

    Journal of Infectious Diseases, Vol. 192, Núm. 12, pp. 2059-2065

  15. Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: Use of high-range Etest strips

    Journal of Clinical Microbiology, Vol. 43, Núm. 9, pp. 4480-4485

  16. CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish Hospital

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 4, pp. 1567-1571

  17. Candida albicans Biology and Pathogenicity: Insights from Proteomics

    Microbial Proteomics: Functional Biology of Whole Organisms (Wiley Blackwell), pp. 285-330

  18. Candida krusei fungaemia: Antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 2, pp. 188-193

  19. Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing

    Journal of Clinical Microbiology, Vol. 43, Núm. 11, pp. 5660-5664

  20. Characterization of natural peptide ligands from HLA-DP2: New insights into HLA-DP peptide-binding motifs

    Immunogenetics, Vol. 56, Núm. 10, pp. 754-759